Literature DB >> 18697430

[Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].

Hikmet Alişkan1, Sule Colakoğlu, Tuba Turunç, Yusuf Ziya Demiroğlu, Ferit Erdoğan, Sule Akin, Hande Arslan.   

Abstract

Pseudomonas aeruginosa and Acinetobacter baumannii which are usually multiply antibiotic resistant, are the most important agents causing infections in intensive care units (ICUs). The aim of this study was to determine the antibiotic sensitivity patterns of P. aeruginosa and A.baumannii that cause infections in ICUs and hospital service units and to follow the variation in resistance between the years of 2003 to 2006. P. aeruginosa (n:1071) and A.baumannii (n:587) strains were isolated from blood, urine, wound, sterile body fluid, sputum and tracheal aspirate cultures of patients who were diagnosed to have infections in ICUs and hospital service units. Conventional methods were used for the identification of the bacteria, and antibiotic sensitivies of the isolates were investigated by disk diffusion method. The most effective antibiotics in 2003 were piperacillin-tazobactam (84%), ciprofloxacin (79%), imipenem (77.5%), and meropenem (69%) for P. aeruginosa strains isolated from ICUs. Decreasing sensitivities to imipenem (51%), meropenem (45%), cefepime (51%), piperacillin (38.5%), ciprofloxacin (72%), cefoperazone/sulbactam (44%) and piperacillin/tazobactam (67%) for P. aeruginosa were found statistically significant in 2006 (p < 0.05). The most effective antibiotics were meropenem (98%) imipenem (94%) and ampicillin/sulbactam (72%) for A.baumannii strains isolated from ICUs in 2003. Decreasing sensitivities to imipenem (60.5%), meropenem (69%), cefepime (24%), ciprofloxacin (14%), gentamicin (13%), and amikacin (19%) for A.baumannii were statistically significant in 2006 (p < 0.05). Our data have indicated that P. aeruginosa and A.baumannii strains isolated in ICUs at our hospital showed multi-drug resistance in 2006, with significant increases since 2003 against certain antimicrobial agents. In conclusion there is an urgent need for effective strategies to control the use of antibiotics in our hospital.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18697430

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  4 in total

1.  Optimized polymeric film-based nitric oxide delivery inhibits bacterial growth in a mouse burn wound model.

Authors:  Elizabeth J Brisbois; Jill Bayliss; Jianfeng Wu; Terry C Major; Chuanwu Xi; Stewart C Wang; Robert H Bartlett; Hitesh Handa; Mark E Meyerhoff
Journal:  Acta Biomater       Date:  2014-06-28       Impact factor: 8.947

Review 2.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

3.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14

4.  Occurrence of bla genes encoding carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii from Intensive Care Unit in a tertiary care hospital.

Authors:  Jayanthi Siva Subramaniyan; Jeya Meenakshi Sundaram
Journal:  J Lab Physicians       Date:  2018 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.